FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,795,404 | -41.5% | 277,047 | +30.0% | 0.05% | -57.9% |
| Q3 2022 | $4,777,000 | +128.6% | 213,168 | +295.5% | 0.13% | +37.0% |
| Q1 2022 | $2,090,000 | +2.5% | 53,897 | +56.6% | 0.09% | -36.1% |
| Q3 2021 | $2,040,000 | +61.4% | 34,427 | +136.4% | 0.14% | -5.9% |
| Q2 2021 | $1,264,000 | +104.5% | 14,566 | +94.2% | 0.15% | +70.0% |
| Q1 2021 | $618,000 | – | 7,500 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |